Colestyramine
Brand names: Questran, Questran Light
Colestyramine is a bile acid sequestrant (anion-exchange resin) used to relieve cholestatic pruritus, to treat bile acid (chologenic) diarrhoea, and as an adjunct in hypercholesterolaemia.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds bile acids in the intestinal lumen to form an insoluble complex that is excreted in the faeces, interrupting enterohepatic recirculation and increasing hepatic conversion of cholesterol to bile acids.
Prescribing in practice
- It can interfere with the absorption of fat-soluble vitamins and many oral drugs, so other medicines should be taken well before or after the resin to avoid binding.
- It is contraindicated in complete biliary obstruction, where bile acid secretion into the gut is absent.
- Constipation is common and prolonged use may aggravate fat malabsorption; consider supplementing fat-soluble vitamins where treatment is prolonged.
Monitoring
Monitor the lipid profile when used for hypercholesterolaemia and review symptom control, bowel habit and, with prolonged use, fat-soluble vitamin status.
Counselling the patient
- Mix the powder with water or a soft food and take it well apart from your other medicines.
- Tell your doctor if you become constipated.
- Take any other tablets at least an hour before or several hours after this medicine.
Evidence & guidelines
Its lipid-lowering and bile-acid-binding effects are well established, supported by long clinical use and reflected in current prescribing references.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021